Auour Investments »

Seres Therapeutics shares owned by Auour Investments

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Auour Investments from 13F filings

Historical chart of Auour Investments investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Auour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Auour Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $13k 17k 0.77
2023-12-31 $21k 17k 1.21
2023-09-30 $25k 17k 1.48
2023-06-30 $81k 17k 4.79

More positions owned by Auour Investments

Spdr Ser Tr Portfolio S&p500 (SPLG)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Ser Tr Portfolio Short (SPSB)
Spdr Ser Tr Portfolio Intrmd (SPIB)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Msci Eafe (IEFA)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ssga Active Etf Tr Ult Sht Trm Bd (ULST)
Spdr Ser Tr Portfli Intrmdit (SPTI)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)

View all positions for Auour Investments

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
Hudson Bay Capital Management
Bank of America Corporation
Millennium Management
Point72 Asset Management
Tang Capital Management
Handelsbanken Fonder AB
Charles Schwab Investment Management
Goldman Sachs Group
Advisor Group Holdings
Hrt Financial
T. Rowe Price Associates
Two Sigma Investments
Lion Point Capital

View all funds holding Seres Therapeutics